Antibodies to tumour necrosis factor in the treatment of severe sepsis: rationale and early clinical experience.
Dept. of Medicine, Royal Postgraduate Medical School, London, England.
J
J
Cohen
D000818:Animals; D004927:Escherichia coli Infections / Q000276:immunology / Q000628:therapy; D016905:Gram-Negative Bacterial Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D051379:Mice; D012772:Shock, Septic / Q000276:immunology / Q000628:therapy*